Serosurvey of Human T-Lymphotrophic Virus Type 1 Secondary Infection among People Living with Hiv/Aids in Dutse Metropolis, North-Western Nigeria

Human T-lymphotrophic virus type 1 (HTLV-1) is a causative agent of tropic spastic paraparesis and adult T-cell leukaemia, Evidence is accumulating that HTLV-1 may be responsible for some degree of subclinical immune suppression that may results in increased rate of HIV. Sixty (60) people living wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammed Yahaya, Usman Aliyu Dutsinma, Yusuf Mohammed
Format: Article
Language:English
Published: Umaru Musa Yar'adua University, Katsina, Nigeria 2018-06-01
Series:UMYU Journal of Microbiology Research
Subjects:
Online Access:https://ujmr.umyu.edu.ng/index.php/ujmr/article/view/255
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Human T-lymphotrophic virus type 1 (HTLV-1) is a causative agent of tropic spastic paraparesis and adult T-cell leukaemia, Evidence is accumulating that HTLV-1 may be responsible for some degree of subclinical immune suppression that may results in increased rate of HIV. Sixty (60) people living with HIV/AIDS consisting of 20 males and 40 females were recruited in this study. HIV diagnosis was confirmed using Nigerian National Serial Algorithm for HIV test. ELISA technique was used for the detection of HTLV-1 IgG and IgM antibodies, and Cyflow partec was used for CD4 count. The prevalence of HTLV-1 IgG and IgM antibodies among HIV subjects was 15% and 6.6% respectively. Male patients have a percentage prevalence of 4(6.6%) and female 5(8.3%) of IgG antibodies, IgM antibodies prevalence was 2(3.3%) for male and female each respectively. CD4 Counts of the HIV subjects was evaluated which reveals that patients with counts 0-200cells/µl tested negative to HTLV-1 IgG and IgM antibodies. Conclusion: The percentage prevalence recorded in this study shows that HTLV-1 infection is relatively high compared to the previous studies even though limited information was obtained in relation to HIV/HTLV-1 co-infection in these study area.  
ISSN:2616-0668
2814-1822